The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus

Objective. To review the current literature investigating the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on the risk factors of cardiovascular disease (CVD). Methods. We conducted a search of PubMed and MEDLINE database, using the term DPP-4 inhibitor in combination with the following term...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousefzadeh, Pegah, Wang, Xiangbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654348/
https://www.ncbi.nlm.nih.gov/pubmed/23710467
http://dx.doi.org/10.1155/2013/459821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654348/
https://www.ncbi.nlm.nih.gov/pubmed/23710467
http://dx.doi.org/10.1155/2013/459821

Ejemplares similares